» Articles » PMID: 37798391

CT-based Deep Learning Model: a Novel Approach to the Preoperative Staging in Patients with Peritoneal Metastasis

Overview
Specialty Oncology
Date 2023 Oct 5
PMID 37798391
Authors
Affiliations
Soon will be listed here.
Abstract

Peritoneal metastasis (PM) is a frequent manifestation of advanced abdominal malignancies. Accurately assessing the extent of PM before surgery is essential for patients to receive optimal treatment. Therefore, we propose to construct a deep learning (DL) model based on enhanced computed tomography (CT) images to stage PM preoperatively in patients. All 168 patients with PM underwent contrast-enhanced abdominal CT before either open surgery or laparoscopic exploration, and peritoneal cancer index (PCI) was used to evaluate patients during the surgical procedure. DL features were extracted from portal venous-phase abdominal CT scans and subjected to feature selection using the Spearman correlation coefficient and LASSO. The performance of models for preoperative staging was assessed in the validation cohort and compared against models based on clinical and radiomics (Rad) signature. The DenseNet121-SVM model demonstrated strong patient discrimination in both the training and validation cohorts, achieving AUC was 0.996 in training and 0.951 validation cohort, which were both higher than those of the Clinic model and Rad model. Decision curve analysis (DCA) showed that patients could potentially benefit more from treatment using the DL-SVM model, and calibration curves demonstrated good agreement with actual outcomes. The DL model based on portal venous-phase abdominal CT accurately predicts the extent of PM in patients before surgery, which can help maximize the benefits of treatment and optimize the patient's treatment plan.

Citing Articles

Using artificial intelligence and statistics for managing peritoneal metastases from gastrointestinal cancers.

Wojtulewski A, Sikora A, Dineen S, Raoof M, Karolak A Brief Funct Genomics. 2024; 24.

PMID: 39736152 PMC: 11735730. DOI: 10.1093/bfgp/elae049.


Mesenchymal stem/stromal cells: dedicator to maintain tumor homeostasis.

Yao J, Sun L, Gao F, Zhu W Hum Cell. 2024; 38(1):21.

PMID: 39607530 DOI: 10.1007/s13577-024-01154-y.


It Is What the Surgeon Does Not See That Kills the Patient.

Sugarbaker P J Clin Med. 2024; 13(8).

PMID: 38673511 PMC: 11051342. DOI: 10.3390/jcm13082238.

References
1.
Lorimier G, Linot B, Paillocher N, Dupoiron D, Verriele V, Wernert R . Curative cytoreductive surgery followed by hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinomatosis and synchronous resectable liver metastases arising from colorectal cancer. Eur J Surg Oncol. 2016; 43(1):150-158. DOI: 10.1016/j.ejso.2016.09.010. View

2.
Amblard I, Mercier F, Bartlett D, Ahrendt S, Lee K, Zeh H . Cytoreductive surgery and HIPEC improve survival compared to palliative chemotherapy for biliary carcinoma with peritoneal metastasis: A multi-institutional cohort from PSOGI and BIG RENAPE groups. Eur J Surg Oncol. 2018; 44(9):1378-1383. DOI: 10.1016/j.ejso.2018.04.023. View

3.
Ji Z, Yu Y, Liu G, Zhang Y, An S, Li B . Peritoneal cancer index (PCI) based patient selecting strategy for complete cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy in gastric cancer with peritoneal metastasis: A single-center retrospective analysis of 125 patients. Eur J Surg Oncol. 2020; 47(6):1411-1419. DOI: 10.1016/j.ejso.2020.11.139. View

4.
van Stein R, Aalbers A, Sonke G, van Driel W . Hyperthermic Intraperitoneal Chemotherapy for Ovarian and Colorectal Cancer: A Review. JAMA Oncol. 2021; 7(8):1231-1238. DOI: 10.1001/jamaoncol.2021.0580. View

5.
Dong D, Fang M, Tang L, Shan X, Gao J, Giganti F . Deep learning radiomic nomogram can predict the number of lymph node metastasis in locally advanced gastric cancer: an international multicenter study. Ann Oncol. 2020; 31(7):912-920. DOI: 10.1016/j.annonc.2020.04.003. View